Chemed (NYSE:CHE) Releases FY24 Earnings Guidance

Chemed (NYSE:CHEGet Free Report) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $23.30-23.70 for the period, compared to the consensus estimate of $23.52. Chemed also updated its FY 2024 guidance to 23.300-23.700 EPS.

Chemed Stock Up 0.2 %

Shares of Chemed stock traded up $1.05 during trading on Wednesday, reaching $617.56. The company’s stock had a trading volume of 67,370 shares, compared to its average volume of 77,478. The company has a market cap of $9.34 billion, a price-to-earnings ratio of 34.46, a PEG ratio of 2.43 and a beta of 0.42. Chemed has a 52-week low of $492.84 and a 52-week high of $654.62. The firm’s 50-day moving average is $623.23 and its two-hundred day moving average is $590.47.

Chemed (NYSE:CHEGet Free Report) last released its earnings results on Tuesday, February 27th. The company reported $6.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.25 by $0.35. Chemed had a net margin of 12.03% and a return on equity of 32.29%. The firm had revenue of $585.90 million during the quarter, compared to analyst estimates of $586.64 million. During the same period last year, the business earned $5.39 earnings per share. The business’s revenue was up 7.2% on a year-over-year basis. On average, equities research analysts anticipate that Chemed will post 21.99 EPS for the current year.

Chemed Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 15th. Investors of record on Monday, February 26th were given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.26%. The ex-dividend date was Friday, February 23rd. Chemed’s dividend payout ratio is presently 8.93%.

Wall Street Analyst Weigh In

CHE has been the subject of a number of recent analyst reports. Royal Bank of Canada lifted their price target on shares of Chemed from $604.00 to $712.00 and gave the stock an outperform rating in a research note on Monday, March 4th. Oppenheimer boosted their price objective on Chemed from $625.00 to $650.00 and gave the company an outperform rating in a report on Thursday, February 29th.

View Our Latest Research Report on CHE

Insider Transactions at Chemed

In related news, EVP Spencer S. Lee sold 2,000 shares of the company’s stock in a transaction dated Thursday, March 28th. The shares were sold at an average price of $641.65, for a total transaction of $1,283,300.00. Following the completion of the sale, the executive vice president now owns 20,760 shares of the company’s stock, valued at approximately $13,320,654. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other Chemed news, CFO Michael D. Witzeman sold 2,650 shares of the stock in a transaction that occurred on Thursday, March 21st. The shares were sold at an average price of $643.14, for a total value of $1,704,321.00. Following the transaction, the chief financial officer now directly owns 2,882 shares in the company, valued at $1,853,529.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Spencer S. Lee sold 2,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 28th. The stock was sold at an average price of $641.65, for a total transaction of $1,283,300.00. Following the transaction, the executive vice president now owns 20,760 shares in the company, valued at $13,320,654. The disclosure for this sale can be found here. Insiders have sold 15,808 shares of company stock valued at $10,184,531 in the last 90 days. 3.32% of the stock is currently owned by company insiders.

About Chemed

(Get Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Featured Stories

Earnings History and Estimates for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.